What is Scitara?
Scitara operates as a global provider of lab-specific integration Platform as a Service (iPaaS) solutions, designed to elevate productivity and ensure data integrity across scientific workflows. Their proprietary cloud-based platform, DLX, serves as a central hub, connecting laboratory instruments, automating complex data workflows, and meticulously monitoring digital transactions. This comprehensive offering is primarily tailored for research and development, bioprocessing, and quality control laboratories within process-based industries. By facilitating seamless data movement and integration, Scitara aims to accelerate scientific discovery and optimize production efficiency, all while adhering to stringent compliance standards. The company's focus on robust data infrastructure positions it as a key player in the digital transformation of scientific operations.
How much funding has Scitara raised?
Scitara has raised a total of $20M across 2 funding rounds:
Series A
$5M
Series B
$15M
Series A (2021): $5M with participation from Northpond Ventures LLC and Flybridge Capital Partners
Series B (2022): $15M led by Northpond Ventures and Flybridge Capital Partners
Key Investors in Scitara
Northpond Ventures LLC
Northpond Ventures is an investment firm that focuses on the life sciences and technology sectors. Their investments typically support companies at various stages of development that are advancing scientific discovery and innovation.
Flybridge Capital Partners
Flybridge is an early-stage venture capital fund with over 20 years of investing experience and more than $1B under management, based in New York and Boston. The firm focuses on providing support to ambitious founders creating innovative companies centered around Artificial Intelligence. Flybridge is dedicated to being hands-on partners during the pivotal early stages of building a startup, specializing in pre-seed and seed investments. Their investment strategy emphasizes AI-native startups across various domains, including vertical SaaS, data infrastructure, and AI-enabled applications to navigate and capitalize on emerging opportunities.
Northpond Ventures
Northpond Ventures is an investment firm that focuses on the life sciences and technology sectors. Their investments typically support companies at various stages of development that are advancing scientific discovery and innovation.
What's next for Scitara?
The recent major strategic investment in Scitara signals a strong commitment from its backers to fuel the company's expansion and further development of its DLX platform. This enterprise-level funding is expected to accelerate Scitara's market penetration, enabling it to enhance its technological capabilities and broaden its customer base within the biopharmaceutical, chemical, and other process-driven industries. The strategic nature of this financing suggests a focus on scaling operations, forging key partnerships, and potentially exploring new market segments. Scitara is poised to leverage this capital to solidify its position as a leader in laboratory informatics and iPaaS solutions, driving innovation in scientific data management and workflow automation.
See full Scitara company page
